Latest Share Repurchases News

CDW delivered a sharp third-quarter sales increase and lifted its quarterly dividend by about 8%, helped by demand for servers, storage, mobile devices and software. The stronger earnings picture came with lower gross margins, higher debt and weaker operating cash flow than a year earlier.

Trimble delivered record annualized recurring revenue and a stronger-than-expected third quarter, while a US$562 million goodwill impairment keeps the headline GAAP picture complicated. The company raised no quantified comparison to its previous outlook, but issued full-year revenue and earnings ranges for 2026.

Insulet delivered a stronger-than-expected third quarter, with revenue up 19.2% and adjusted earnings per share rising nearly 60%. The diabetes-device maker also raised its operating-margin outlook and authorised a US$1 billion share repurchase programme.

Emerson delivered a stronger fiscal 2026 finish, with fourth-quarter sales up 7%, GAAP earnings per share up 24% and free cash flow up 9%. The industrial automation group also raised its dividend and outlined roughly 5% growth for fiscal 2027.

Stanley Black & Decker raised its 2026 earnings and free cash flow guidance after tariff refunds helped drive a sharp third-quarter profit recovery. Underlying organic growth improved, but the refund accounted for a substantial portion of the quarter’s earnings lift.

Embelton is seeking shareholder approval to leave the ASX, arguing that thin trading and annual listing costs of about $160,000 no longer justify the quotation. The company also proposes an $11 per share buy-back for other shareholders, subject to approval.

Prudential Financial delivered lower third-quarter adjusted earnings as a sales suspension in Japan cut into an otherwise mixed performance. PGIM attracted strong third-party inflows and US annuity sales reached a record, but the company’s central earnings engine weakened year on year.

Assurant lifted its 2026 earnings outlook after reporting strong third-quarter growth across its Lifestyle and Housing businesses. The insurer also plans to increase share repurchases to US$350 million, although catastrophe losses and reserve development remain important variables.

International Flavors & Fragrances raised the lower end of its 2026 sales and adjusted EBITDA guidance after broad-based third-quarter growth. The stronger operating result sits alongside a US$134 million pre-tax continuing-operations loss and a costly Food Ingredients separation still awaiting completion.

Arista Networks delivered third-quarter revenue well above its own guidance, with sales reaching US$3.66 billion and GAAP net income hitting US$1.56 billion. The networking specialist is now guiding to as much as US$4.0 billion in fourth-quarter revenue as it expands its AI infrastructure portfolio.

Amgen delivered 8% third-quarter revenue growth and a 19% increase in GAAP diluted EPS, while newer medicines continued to expand. The result came alongside sharp declines in Prolia and XGEVA sales from biosimilar competition and a busy pipeline of late-stage programmes.

Booking Holdings delivered strong third-quarter booking and adjusted earnings growth, but a US$900 million revenue reduction linked to an FTC matter pushed reported revenue and net income lower. Its fourth-quarter guidance also points to softer travel demand and continuing disruption from the Middle East conflict.